Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

14 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Alternative Dosing Schedules of Azacitidine: A Real-World Study Across South American Centers.
Castelo L, da Silva WF, Lincango M, Buccheri V, Perusini A, Arbelbide J, Iastrebner M, Gonzalez J, Pereyra P, Pereira TDM, Marchi LL, Rocha V, Belli CB, Velloso EDRP. Castelo L, et al. Among authors: iastrebner m. Clin Lymphoma Myeloma Leuk. 2024 Feb 14:S2152-2650(24)00062-4. doi: 10.1016/j.clml.2024.02.003. Online ahead of print. Clin Lymphoma Myeloma Leuk. 2024. PMID: 38462425 No abstract available.
Severe thrombocytopenia as a predictor of survival and response to hypomethylating agents in myelodysplastic syndromes: A Latin-American cohort of 212 patients.
Lazzarino C, Arbelbide J, Schuster S, Crisp R, González J, Tavares R, Perusini MA, Di Stefano M, Pintos N, Espinosa D, Pimentel M, Rosenhain M, Serrano JC, Enrico A, Iastrebner M, Belli CB. Lazzarino C, et al. Among authors: iastrebner m. Am J Hematol. 2020 Dec;95(12):E323-E326. doi: 10.1002/ajh.25987. Epub 2020 Oct 1. Am J Hematol. 2020. PMID: 32864747 Free article. No abstract available.
Myelodysplastic syndromes in Latin America: state of the art.
Crisp R, Grille S, Belli C, Diaz L, Undurraga S, Navarro J, Vidal G, Gusmao B, Reyes J, Huaman F, Magalhaes S, Barroso F, Ovilla R, Flores G, Choque JA, Di Stefano M, Salinas V, Iastrebner M; Latin-American Group for Myelodysplastic Syndromes GLAM. Crisp R, et al. Among authors: iastrebner m. Blood Adv. 2018 Nov 30;2(Suppl 1):60-62. doi: 10.1182/bloodadvances.2018GS110862. Blood Adv. 2018. PMID: 30504205 Free PMC article. No abstract available.
Flow cytometry diagnosis in myelodysplastic syndrome: Current practice in Latin America and comparison with other regions of the world.
Grille S, Iastrebner M, Lorand-Metze I, van der Velden VHJ, Ikoma MRV, Vidal-Senmache G, Colado E, Rabelo-Carrasco LJ, Blanco A, Huamán-Garaicoa F, O'Connor JE, Cao Pochintesta C, Jensen E, Bacal NS, Díaz L, Lens D. Grille S, et al. Among authors: iastrebner m. Leuk Res. 2019 Apr;79:69-74. doi: 10.1016/j.leukres.2019.01.009. Epub 2019 Jan 24. Leuk Res. 2019. PMID: 30773246
Consensus proposal for revised International Working Group 2023 response criteria for higher-risk myelodysplastic syndromes.
Zeidan AM, Platzbecker U, Bewersdorf JP, Stahl M, Adès L, Borate U, Bowen D, Buckstein R, Brunner A, Carraway HE, Daver N, Díez-Campelo M, de Witte T, DeZern AE, Efficace F, Garcia-Manero G, Garcia JS, Germing U, Giagounidis A, Griffiths EA, Hasserjian RP, Hellström-Lindberg E, Iastrebner M, Komrokji R, Kulasekararaj AG, Malcovati L, Miyazaki Y, Odenike O, Santini V, Sanz G, Scheinberg P, Stauder R, van de Loosdrecht AA, Wei AH, Sekeres MA, Fenaux P. Zeidan AM, et al. Among authors: iastrebner m. Blood. 2023 Apr 27;141(17):2047-2061. doi: 10.1182/blood.2022018604. Blood. 2023. PMID: 36724453 Free article.
14 results